Welcome to FECCIA
We represent the interests of over 100,000 managerial staff in Europe
Through its national member organisations, FECCIA represents the interests of over 100,000 managerial staff in Europe and coordinates the communication and cooperation with the European Chemical Employers Organisation ECEG and the trade union.
FECCIA contributes to the development of solutions to all relevant socio-political issues concerning managers in the chemical industry. As a member of CEC-European Managers, FECCIA is active in the Social Dialogue Committee of the European Commission.
Novo Nordisk to Invest €5.6 Billion in Expansion of API Production in Denmark
Danish drugmaker Novo Nordisk plans to invest more than 42 billion Danish kroner (about €5.6 billion) starting in 2023 to expand existing manufacturing facilities at the company’s Kalundborg, Denmark, site to meet future market demands.
AstraZeneca Invests $245 Million in French Biotech Cellectis
Anglo-Swedish drugmaker AstraZeneca entered into a collaboration and investment agreement with Cellectis, a French clinical-stage biotechnology company, to accelerate the development of therapeutics across oncology, immunology and rare diseases.
Daiichi Sankyo and Merck & Co. Collaborate on Three DXd ADCs Worldwide
Daiichi Sankyo and Merck & Co. to co-develop and commercialize three of Daiichi Sankyo’s DXd antibody-drug conjugate (ADC) candidates worldwide except for Japan where Daiichi Sankyo retains exclusive rights. Merck to pay Daiichi Sankyo up to €20.8 billion for the collaboration.